Gaas, Baby Girl -.
HRN: 22-39-09 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/27/2022
01/03/2023
IVT
33 Mg
24 Hrs
Neonatal Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes